Red yeast rice is fermented rice sold as a dietary supplement, used mainly for cholesterol management. Its main active compound is chemically identical to a prescription cholesterol-lowering drug, so effects and risks follow that drug's pattern. Blood cholesterol lowering has the strongest evidence, though one short trial found no change. Muscle, liver, and kidney injury are the main harms. Product content varies; fungal toxin has been found in many products. (Full Review)
| Marker | Target | Why |
|---|---|---|
| LDL cholesterol | Below 100 mg/dL (coronary disease or equivalent); below 130 (two or more risk factors); below 160 (zero or one risk factor) | Marker expected to change |
| ALT and AST | ALT about 7–56 U/L, AST about 10–40 U/L (standard reference range) | Safety check; unexplained persistent elevation contraindicates lovastatin |
| Creatine kinase (CK) | About 30–200 U/L (standard reference range) | Safety check; myopathy is defined as above 10 times the upper limit of normal |
| eGFR and electrolytes | No established target; track change from own baseline | Safety check; the Japanese cases defined low eGFR as below 60 mL/min/1.73 m² |
| HbA1c and fasting glucose | No established target; track change from own baseline | Safety check; the label reports statin-class increases |
Cadence: Baseline before starting; lipid panel, liver enzymes, and kidney function with electrolytes repeated at about 8 to 12 weeks, then every 6 to 12 months; creatine kinase checked promptly if muscle symptoms occur; glucose markers rechecked at the 6- to 12-month visits